Enveric Receives U.S. Patent for Sleep, CNS Therapeutics
The patent strengthens Enveric Biosciences, Inc.
Enveric Biosciences Inc. (ENVB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sio Capital Michael Castor | 180,000 | $248,400 | 0.04% | |
| 2. | Ikarian Capital Neil Shahrestani | 100,002 | $138,003 | 0.01% | |
| 3. | Renaissance Technologies Jim Simons | 32,058 | $44,240 | 0% | |
| 4. | Armistice Capital Steven Boyd | 32,000 | $44,160 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 13,965 | $19,272 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.14 | 1,000 | $2,140.00 | 1,000 | 2023-09-15 | Filing | |
| $4.12 | 12,121 | $49,877.92 | 2,191,346 | 2017-11-17 | Filing | |
| $4.12 | 100,000 | $411,500.00 | 2,972,592 | 2017-11-17 | Filing | |
| $4.12 | 145,450 | $598,526.75 | 648,779 | 2017-11-17 | Filing | |
| $6.50 | 1,303 | $8,468.72 | 13,910 | 2017-10-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.29 | 58,850 | $17,243.05 | 2,250,000 | 2018-11-16 | Filing | |
| $0.29 | 1,850 | $543.90 | 2,308,850 | 2018-11-16 | Filing | |
| $0.30 | 6,657 | $1,963.82 | 2,310,700 | 2018-11-16 | Filing | |
| $0.30 | 200 | $59.02 | 2,317,357 | 2018-11-16 | Filing | |
| $0.30 | 15,251 | $4,575.30 | 2,317,557 | 2018-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 35,417 | $48,875 | 0.01% | |
| 2. | 30,142 | $41,596 | 0% | |
| 3. | 18,990 | $26,206 | 0% | |
| 4. | 11,814 | $21,882 | 0% | |
| 5. | 14,912 | $20,579 | 0% |
News See All
12 AI News and Ratings Investors Probably Missed
AI is transforming industries at a very fast pace, with businesses integrating AI agents to improve efficiency and customer interactions.
10 Most Promising Psychedelic Stocks According To Analysts
Psychedelic drugs encompass a range of chemicals, including lysergic acid diethylamide (LSD) and plant-derived compounds.
Hedge Fund Resource Center